Cargando…
The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
The appearance of new disease-modifying therapies in multiple sclerosis (MS) has revolutionized our ability to fight inflammatory relapses and has immensely improved patients’ quality of life. Although remarkable, this achievement has not carried over into reducing long-term disability. In MS, clini...
Autores principales: | Ben-Shalom, Ido, Karni, Arnon, Kolb, Hadar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745199/ https://www.ncbi.nlm.nih.gov/pubmed/35008899 http://dx.doi.org/10.3390/ijms23010474 |
Ejemplares similares
-
The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019) -
Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019) -
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
por: Kolb, Hadar, et al.
Publicado: (2021) -
Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007) -
Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)